testo-alternativo
Advances in Dermatology: Vitiligo, JAK Inhibitors, and Emerging Therapies

Advancements in Dermatology: A Weekly Review

Dermatologia e Venerologia

Advances in Dermatology: Vitiligo, JAK Inhibitors, and Emerging Therapies

This episode explores cutting-edge dermatological treatments including JAK inhibitors for vitiligo, tranexamic acid applications, and photodynamic therapy advances, plus crucial updates on syphilis diagnostics and global cancer screening disparities.

Login or Register to listen to this episode

Bibliography

1. Vitiligo.
Authors: Böhm M, Tanew A
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2025 Aug
PMID: 40788636
DOI: 10.1111/ddg.15706


2. JAK-STAT pathway inhibitors in dermatology.
Authors: Miot HA, Criado PR, de Castro CCS, et al.
Journal: Anais brasileiros de dermatologia, 2023 Sep-Oct
PMID: 37230920
DOI: 10.1016/j.abd.2023.03.001


3. Update on syphilis diagnostics.
Authors: Sweitzer S, Duncan JA, Seña AC
Journal: Current opinion in infectious diseases, 2025 Feb 1
PMID: 39641765
DOI: 10.1097/QCO.0000000000001073


4. THE USE OF TRANEXAMIC ACID IN DERMATOLOGY.
Authors: Gaćina K, Krstanović Ćosić A
Journal: Acta clinica Croatica, 2023 Aug
PMID: 38549597
DOI: 10.20471/acc.2023.62.02.16


5. Photodynamic therapy in dermatology: established and new indications.
Authors: Balakirski G, Lehmann P, Szeimies RM, et al.
Journal: Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2024 Dec
PMID: 39226531
DOI: 10.1111/ddg.15464


6. Cervical cancer screening programmes and age-specific coverage estimates for 202 countries and territories worldwide: a review and synthetic analysis.
Authors: Bruni L, Serrano B, Roura E, et al.
Journal: The Lancet. Global health, 2022 Aug
PMID: 35839811
DOI: 10.1016/S2214-109X(22)00241-8

Comments

Please Login to leave a comment.

No comments yet.